Resources

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus.

This document is the technical supplement to the Australian Respiratory Surveillance Report (ARSR) series. It describes the technical background and considerations to help interpret the ARSR surveillance data reported nationally for COVID-19, influenza and respiratory syncytial virus.

This document outlines how the National Communicable Disease Surveillance Dashboard works using the new Microsoft Power BI user interface.

This document gives guidelines on how laboratories should test for gonorrhoeae using nucleic acid detection.

These procedures explain how laboratories should collect and handle samples from patients with suspected viral haemorrhagic fevers.

This document is a position statement on the use of antiviral medication for laboratory staff working with H5/pandemic influenza A virus.

This guidance note covers known Australian tick-borne diseases.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 9 December 2024 to 5 January 2025.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 6 to 19 January 2025.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 20 January to 2 February 2025.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 3 to 16 February 2025.

This guidance document presents a rational and pragmatic approach to support laboratory looking into preventing and controlling heater–cooler unit-related infections.

This report and accompanying table provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 17 February to 2 March 2025.

This document explains how to transport Hendra specimens (blood, nasal/throat swabs, urine).

This document is for clinicians and laboratory professionals. It gives information about referral practices for PCR positive samples when isolate serotyping is not available.

This document explains how to collect, handle, package and transport viral haemorrhagic fever samples.

Information for physicians on referring patients with suspected mpox. It also includes how to safely and correctly collect and transport specimens.

This document explains how to collect and transport specimens, and the referral pathway to confirm poliovirus detected in wastewater.